Changes in APRI and FIB-4 in HBeAg-negative treatment-naive...

  • Main
  • 2019 / 5
  • Changes in APRI and FIB-4 in HBeAg-negative treatment-naive...
Clinical and Experimental Medicine 2019 / 5

Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy

Liu, Ruyu, Guo, Jiang, Lu, Yao, Zhang, Lu, Shen, Ge, Wu, Shuling, Chang, Mi, Hu, Leiping, Hao, Hongxiao, Li, Minghui, Xie, Yao
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical and Experimental Medicine
DOI:
10.1007/s10238-019-00560-z
Date:
May, 2019
File:
PDF, 808 KB
2019
Conversion to is in progress
Conversion to is failed